New Banexi fund to incorporate biotech

Banexi Corp., the international merchant banking arm of Banque Nationale de Paris, and Nazem & Co., a Menlo Park, Calif., venture capital firm, announced plans to raise a $40-60 million U.S. venture capital fund.
The Transatlantic Fund will focus on certain segments of the electronics and health care industries, including health care